clinical trial · NCT03773770

Expanded Access to Triheptanoin

$RARE →·—·available

Long Chain Fatty Acid Oxidation DisordersTriheptanoin

brief summary

Expanded access may be provided for qualified patients who have limited treatment options and are not eligible for a clinical trial.

started

—

primary completion

—

completion

—

last updated

Apr 13, 2026

detailed description

Long Chain Fatty Acid Oxidation Disorders (LC-FAOD) and other Non-FAOD conditions, where applicable: Expanded access may be available outside of the US in countries prior to approval by the local regulatory agencies.

For full details, please visit the links provided below.

full record on clinicaltrials.gov ↗

sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol